Epiminder Ltd
EPI
Company Profile
Business description
Epiminder Ltd is a medical device and information solutions company focused on developing diagnostic and treatment tools for epilepsy. Its system is a sub-scalp device for continuous monitoring of electrographic brain activity and a set of information solutions, providing patients and their healthcare professionals with detailed data over an extended period.
Contact
525 Collins Street
210 West Podium, Mezzanine 2
MelbourneVIC3000
AUST: +61 452521634
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
Eli Lilly receives FDA approval to add another oral GLP-1 to market
Wide moat Eli Lilly receives FDA approval for obesity pill.
stocks
Our top ASX picks in every sector
These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
stocks
Which of the 3 giant AI IPOs should you buy?
OpenAI, Anthropic, and Databricks are expected to go public this year at massive valuations.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,774.90 | 124.80 | -1.40% |
| CAC 40 | 7,896.44 | 84.83 | -1.06% |
| DAX 40 | 22,889.17 | 409.72 | -1.76% |
| Dow JONES (US) | 46,100.96 | 464.78 | -1.00% |
| FTSE 100 | 10,378.50 | 13.71 | 0.13% |
| HKSE | 25,116.53 | 177.50 | -0.70% |
| NASDAQ | 21,613.79 | 227.15 | -1.04% |
| Nikkei 225 | 52,463.27 | 1,276.41 | -2.38% |
| NZX 50 Index | 12,902.15 | 76.28 | 0.59% |
| S&P 500 | 6,522.75 | 52.57 | -0.80% |
| S&P/ASX 200 | 8,579.50 | 105.50 | -1.21% |
| SSE Composite Index | 3,919.29 | 29.27 | -0.74% |